Efficacy and Safety of Leymovir Versus Valganciclovir in Prevention of Cytomegalovirus Infection and Cytomegalovirus Disease in Chinese Kidney Transplant Recipients | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Efficacy and Safety of Leymovir Versus Valganciclovir in Prevention of Cytomegalovirus Infection and Cytomegalovirus Disease in Chinese Kidney Transplant Recipients	Kidney Transplant	Recruiting	Phase 4	2025-12-05		NCT07266467

18 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Beijing Chao Yang Hospital	88
Beijing Tsinghua Changgeng Hospital	16
Chinese People's Liberation Army Northern Theater Command General Hospital	1
Eastern Theater General Hospital	1
First Affiliated Hospital Xi'an Jiaotong University	142
First Affiliated Hospital, Sun Yat-Sen University	113
Nanfang Hospital, Southern Medical University	248
Qianfo Mountain Hospital, Shandong Province	1
RenJi Hospital	264
Second Affiliated Hospital of Guangzhou Medical University	70
Shanghai Zhongshan Hospital	347
Shu lan Hospital	1
The Affiliated Hospital of Qingdao University	124
The First Affiliated Hospital of Anhui Medical University	85
The First Affiliated Hospital of Zhengzhou University	203
The First Hospital of Jilin University	154
The Second Xiangya Hospital, Central South University	2
Tongji Hospital	276

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
The First Affiliated Hospital of Xi 'an Jiaotong University	Xi'an	China	1